Analysis of the solid-state conformations of six active and two inactive anti-human immunodeficiency virus nucleoside analogues is used to correlate conformational features with the relative activities of the compounds.
Nucleoside analogues that lack the 3'-hydroxyl group have been extensively studied (1-4) as potential agents against human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). 3'-Azido-3'-deoxythymidine (3'-azido-2',3'-dideoxyribosylthymine, N3ddT ; also called AZT, Retrovir, and Zidovudine) (5) (6) (7) is at this time the only drug licensed by the Food and Drug Administration specifically for the treatment of AIDS patients. N3ddT and its analogues are inhibitors of HIV-1 reverse transcriptase (RTase), the enzyme that catalyzes the transcription of the viral RNA to DNA. Nucleoside 5'-triphosphates are the active substrates of RTase. N3ddT is converted to N3ddTTP by thymidine kinase and thymidylate kinases of the host cell (8) . N3ddTTP competes with the natural substrate, thymidine 5'-triphosphate (dTTP), for binding to RTase. The RTase binding constant ofN3ddTTP (K, = 4.0 nM) is higher than that of dTTP (K, = 0.5 ,uM) (9) . Uptake of N3ddTTP in the DNA chain that is being synthesized results in chain termination (2) because of inability to form the 3',5'-phosphodiester link to the next nucleotide.
Closely related 2',3'-dideoxynucleosides can differ greatly in anti-HIV-1 activity levels (10, 11) . 2',3'-Dideoxycytidine (ddC) (EC50 = 0.011 uM), ¶ 2',3'-dideoxyadenosine (ddA) (EC50 = 0.91 ,uM), and 3'-deoxythymidine (ddT) (EC50 = 0.17 ,uM) are quite active, but 2',3'-dideoxyuridine (ddU) (EC50 = 96.8 ,LM) and 2',3'-dideoxy-5-ethyluridine (EC50 = 4.9 ,uM) are much less active. Addition of a 3'-azido group increases the activity ofthe thymidine-and uridine-related compounds:
3'-azido-2',3'-dideoxyuridine (N3ddU, CS-87) (EC50 = 0.18-0.46 ,uM), N3ddT (EC50 = 0.002-0.009 AM), and 3'-azido-2',3'-dideoxy-5-ethyluridine (N3ddeU, CS-85) (EC5o = 0.56-1.00 AM). 3'-(Propyl-2-ene)-2',3'-dideoxyuridine (peddU) has very low activity (EC50 = 100.0 ,uM), suggesting that not only the size but also the polarity of the 3' substituent are important. The differences in antiviral activity may be caused by differences in the binding to RTase or by different rates of phosphorylation. It is also not yet fully established whether chain termination is required or whether the reversible competitive binding of the nucleotide analogue to RTase would be sufficient for activity (12) .
Correlation of activity with structural information, including data regarding the molecular conformation, polarity, and intermolecular interactions, can be used to determine the molecular basis for the activity of the compounds. The high flexibility of the nucleoside molecules is well documented (13, 14) . This conformational freedom precludes conclusions from a single or a few crystal structures, but analysis of a larger sample of compounds should indicate trends that certain conformations may be favored. In this paper we compare the molecular conformations, determined by x-ray crystallography, of eight compounds with various activity levels. These compounds, shown in Fig. 1 , include six active compounds, N3ddT (AZT), N3ddU (CS-87), N3ddeU (CS-85), ddC, ddA, and ddT, three of which have a 3'-azido substituent, and two inactive compounds, ddU and peddU. ddT and ddU were chosen because oftheir lower activity compared to their 3'-azido analogues. peddU was included in the study as an example of an inactive compound with a 3' substituent similar in size to, but less polar than, the azide group.
MATERIALS AND METHODS
Crystal Structure Determination. The crystal structures of six of the compounds were reported previously (15) (16) (17) (18) . The structures of ddT and ddU are reported here. The compounds were prepared as previously described (10, 11) . Crystallization, data collection, and structure refinement parameters are listed in Table 1 . 11 The x-ray intensity data were measured on an Enraf-Nonius CAD4 diffractometer. Blessing's program package (19) was used for the data reduction. The structures were determined by direct methods, using the program MULTAN (20) . The structures were refined by full-matrix least-squares. Hydrogen atom coordinates, except those of the hydrogens on 05' of both ddT molecules and C5' of ddT molecule A, were determined from difference maps. The numbering scheme shown in Fig. 1 and the designations used in describing the nucleoside torsion angles are consistent with the rules of the IUPAC-IUB Commission on Biochemical Nomenclature (21) .
Nucleoside Geometry. The conformations ofnucleosides and their analogues have been extensively reviewed by Sundaralingam (13) and by Saenger (14) . The three essential parameters are the geometry of the glycosyl link, the rotation about the exocyclic C4'-C5' bond, and the puckering of the sugar ring. The torsion anglesx(C2-N1-C1'-04') and y (C3'-C4'-C5'-05') describe the orientations of the base and the 5'-hydroxyl group relative to the sugar ring. The puckering ofthe five-membered sugar ring is a continuous displacement of one (envelope) or two atoms (twist) out of the plane of the others. This displacement can be described by the pseudorotational phase angle P, which depends on all intra-ring torsion angles, and the maximum torsion angle v,,. (22) .
Our paper (15) analyzing the crystal structures of N3ddT, N3ddU, and N3ddeU included a report on the distribution of the torsion angles X and y for 138 thymidine and uridine analogues found in the Cambridge Structural Database (23) . In most structures, the glycosyl link is anti (C6 above the sugar ring; -160°< X < -80°) with a maximum at about -130°. Only about 10% of the structures have syn conformations (500 < X < 900). The orientation of the 05'-hydroxyl group shows a trimodal distribution, centered at y = 600, 180°, and -60°. The y = 600 conformation has 05' above the sugar ring between 04' and C3', and y = 1800 places the C5'-05' bond trans to the C3'-C4' bond. The number of observations at 'y = 600 is about 3 times larger than the other two groups. Two preferred conformations of the sugar ring have been reported, one with P between 00 and 360 and one with P between 1440 and 1900. These values represent conformations centered about the envelope conformations C3'-endo (P = 180) and C2'-endo (P = 1620), respectively. Endo and exo refer to the conformations that have the atom at the same or opposite side of the sugar ring as the base. The two torsion angles and the sugar ring puckering are highly correlated. The C2'-endo and C3'-endo conformations are correlated with glycosyl conformations with -144°< X < -115°a nd -180°< X < -1380, respectively. Purine C3'-endo *Letters A, B, C, and D refer to independent observations of the conformation in the crystal structure.
other anti-HIV nucleosides in Table 2 . The intermolecular hydrogen-bonding geometries are listed in Table 3 . The conformation of ddU is very similar to that of peddU. The intermolecular interactions in this structure do not include base pairing or parallel base stacking. ddT crystallizes with two molecules in the asymmetric unit. These are connected by intermolecular hydrogen bonds that form base pairing of the symmetric N3-HN3..O02 type. Parallel base stacking allows for overlap of about one-third of the base of molecule B (x, 1 + y, z) over the base of molecule A. The distance between the planes of the stacked bases is about 3.4 A. The two molecules have very different conformations. The conformation of molecule A is very similar to the conformation of molecule B in the structure of N3ddT. The sugar ring conformation is C3'-exo, identical to that observed for several of the active analogues. The second molecule has a sugar ring conformation that is similar to that of ddU, but its glycosyl link geometry is similar to that of molecule A of N3ddT. The 5'-hydroxyl group of molecule A of ddT is disordered. Occupation parameters refined to 0.67 and 0.33 for the positions with y = 66.0(7)°and y = 169(1)0, respectively, and were held fixed during the final cycles. The Ni-Cl' bond lengths show the typical dependence on the X angle: longer when the angle is closer to 1800.
Comparison of Anti-HIV Nucleoside Conformations. Table  2 lists the most important conformational parameters for all 13 observations of the eight compounds included in this study. The active anti-HIV nucleosides have unusual conformational features in the glycosyl link geometry and the sugar ring puckering. Seven observations have a X angle between -160°and -175°. This conformation is at the extreme end of the range of observed anti conformations. It places the C1'-04' bond almost in the plane of the conjugated system of the base, altering the electron density at Cl' and bringing 04' in close contact with the hydrogen of C6 of the base. Structural effects are lengthening of the N1-C1' bond and shortening of the C1'-04' bond. The nearly -90°X angle of ddA minimizes steric hindrance between the sugar and the base. This conformation is not unusual for purine nucleosides. All y angles are either -60°or '180°, but no correlations between sugar ring puckering and the y angle, which is very dependent on the intermolecular hydrogen bonding of 05', are observed. Fig. 3 shows the comparison of the pseudorotational phase angles (P) of all 13 observations with those of 44 other thymidine or 2'-deoxyuridine analogues found in the Cambridge Crystallographic Database (23) . The criteria used in the search were as follows: the 2',3'-dideoxyuridine skeleton with any C5 substituent, no C6 substituent, no C2' substituent, any C3' substituent, and any 05' substituent. 3',5'-Cyclic phosphate analogues were excluded because of the possible restrictive effect of this link. This group of compounds should be representative of the normal sugar ring conformation of 2'-deoxyuridine and thymidine compounds. The majority of the compounds have a C2'-endo conformation (P = 1620), with four in the C3'-endo range (P = 18°) and five in the C4'-exo range (P = 54°). All but 1 of the 11 observations of the active anti-HIV compounds have P in the range 165-220°(C2'-endo to C4'-endo) and are equally distributed about P = 1980 (C3'-exo). The only exception is one of the two molecules of ddT. The database analogues that have P > 1800 are thymidine, the natural substrate for (7) 2.04 (6) 160 (4) N3A..02B (x, y, z)
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2.794 (3) 2.05 (4) 167 (3) Chemistry: Van thymidine kinase, and two closely related compounds: 5-vinyl-2'-deoxyuridine and 5-(2-bromovinyl)-2'-deoxyuridine. The inactive compounds have P in the range 5-20°, close to the C3'-endo (P = 160) conformation. The extreme glycosyl link conformations and sugar ring puckerings appear to be correlated. The molecules of the active compounds that have aX angle of about -170°have a pseudorotational phase angle P of 200-2150, or a conformation between C3'-exo and C4'-endo.
Intermolecular Interactions. The intermolecular interactions differ greatly from one structure to the other. The thymidine analogues all crystallize with two molecules in the asymmetric unit. These molecules form base pairing with hydrogen bonds from N3 to 02 or 04 and base stacking interactions. N3ddeU has four molecules in the asymmetric unit, forming two sets of dimers connected by base pairing, one based on symmetric N3-HN3..02 hydrogen bonds and one based on N3-HN3..04 hydrogen bonds. The uridine compounds N3ddU, ddU, and peddU do not form base pairing or base stacking interactions. This difference might suggest that the presence or absence of a substituent on C5 affects the interaction between the bases. ddC and ddA also do not form base pairing and base stacking interactions. The intermolecular interactions do not appear to affect the molecular conformations other than the rotation about the C4'-C5' bond.
DISCUSSION
The analysis of the conformation of eight anti-HIV nucleoside analogues shows that active compounds have a preference (10 observations out of 11) for a sugar ring conformation that is centered around the C3'-exo conformation. These conformations are not commonly observed for other nucleoside analogues, which prefer C3'-endo and C2'-endo conformations. The 3'-azido substituent appears to stabilize the C3'-exo conformation and also enhances the activity when compared to the corresponding 2',3'-dideoxynucleosides.
The most extreme sugar ring conformations (P > 2000) appear linked with an extreme glycosyl link geometry (X < -1700). No other conformational parameters or packing effects appear to cause the sugar ring puckering differences between active and inactive compounds. The inactive compounds, ddU and peddU, have C3'-endo conformations. Based on molecular mechanics calculations, Herzyk et al. (25) reported that the C3'-endo conformation would be the minimum energy conformation of N3ddT. However, recent results** indicate that the C3'-exo conformation would be favored for N3ddT, N3ddU, and N3dd'U. This is consistent with our crystallographic observations.
Interpretation of these observations in terms of the biological activity requires consideration of the mechanism of action of the nucleosides. Birnbaum et al. (16) proposed that the C3'-exo conformation of ddC may represent a transition state of the substrates of cytidine kinase or RTase. Camerman et al. (26) proposed that N3ddT is active because the 3'-azido group would fit in the space required for a 3'-phosphate group and would therefore not interfere with the binding to RTase and that the polarity of the substituent would promote binding. This would explain the high activity of N3ddT and N3ddU when compared to ddT and ddU, but it does not account for the activity of ddC, ddA, and ddT.
We propose that the conformational data need to be interpreted in terms of the position of the 5'-hydroxyl group relative to the base because 05' is the site of phosphorylation and of incorporation into the DNA chain. Two parameters determine the location of the 5'-hydroxyl group: the rotation about the C4'-C5' bond, described by the y angle, and the puckering of the sugar ring. The former is greatly affected by intermolecular interaction and is ignored in this analysis. However, changing from a C3'-endo envelope conformation to a C3'-exo conformation moves C5' from an equatorial to an axial position without affecting the position of the base, which is axial. The difference between the axial or equatorial positions of C5' has a large effect on the distance of C5' and 05' to N1 of the base and on the location of 05' relative to the rest of the molecule. This is illustrated in Fig. 4 , which shows the superposition of peddU (C3'-endo) on both of the N3ddT molecules (C3'-exo), prepared by least-squares fitting of the atoms N1, Cl', C2', and 04'. Division of all molecules into two groups based on the C4'-C5' conformations (y = 60°and 'y = 1800) and fitting them on the corresponding N3ddT molecule (A, y = 51°, or B, y = 1730) allows analysis of the effect ofthe ring puckering on the 05' position without interference of rotational freedom about the C4'-C5' bond. All molecules that have the C3'-exo conformations have 05' within 0.89 A of the N3ddT position, whereas the 05' atoms of the molecules that have the C3'-endo conformation are 1.68-2.20 A from the N3ddT positions.
The preferred C3'-exo conformation of active compounds, stabilized by the 3'-azido substituent when present, may be the conformation required for effective interaction with the nucleoside kinases. The energy differences between C3'-exo and C3'-endo conformations are not large and the barrier between them is probably very low. But having a larger population of molecules in the conformation that is more easily bound by the kinase may well result in more efficient phosphorylation. Enhanced compound a competitive inhibitor for RTase. Our observations suggest that a potentially successful strategy for the design of improved anti-HIV agents must take this stabilization of the sugar ring conformation into account. Further examination of this proposal by means of the synthesis and testing of compounds that restrict the sugar ring to either one of the conformations may be useful for the development of new anti-HIV compounds.
